Renovis Restructures To Focus On Advancing Its Neurological And Inflammatory Disease Programs Into Clinical Trials

... Renovis, Inc. (Nasdaq: RNVS) today announced that it has reduced its workforce by approximately 40 percent of its positions as part of a restructuring plan intended to significantly reduce spending while maintaining the research and development capabilities needed to advance the Company's late-stage preclinical drug discovery programs. [click link for full article] ...